GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Quantum Computing Inc (NAS:QUBT) » Definitions » YoY EBITDA Growth

QUBT (Quantum Computing) YoY EBITDA Growth : 37.97% (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Quantum Computing YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Quantum Computing's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 37.97%.

Quantum Computing's EBITDA per Share for the three months ended in Sep. 2024 was $-0.05.


Quantum Computing YoY EBITDA Growth Historical Data

The historical data trend for Quantum Computing's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Computing YoY EBITDA Growth Chart

Quantum Computing Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -65.41 -1.76 -9.84 47.80

Quantum Computing Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.60 38.52 20.48 52.08 37.97

Quantum Computing YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Quantum Computing's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.332--0.636)/ | -0.636 |
=47.80 %

Quantum Computing's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(-0.049--0.079)/ | -0.079 |
=37.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quantum Computing YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Quantum Computing's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Computing Business Description

Traded in Other Exchanges
N/A
Address
No.5 Marine View Plaza, Suite 214, Hoboken, NJ, USA, 07030
Quantum Computing Inc is an American company utilizing non-linear quantum optics (optical devices whose output due to quantum effects is exponentially, not linearly, related to inputs) to deliver quantum products for high-performance computing applications. QCi's products are designed to operate at room temperature and use low power at an affordable cost. The Company's portfolio of core technology and products offer new capabilities in the areas of high-performance computing, artificial intelligence, cyber security as well as remote sensing applications.
Executives
Robert Liscouski director, 10 percent owner, officer: President, CEO C/O IMPLANT SCIENCES CORPORATION, 500 RESEARCH DRIVE, WILMINGTON MA 01887
Christopher Boehmler officer: Chief Financial Officer 1350 E CAPITOL ST NE, WASHINGTON DC 20003
Yuping Huang director, 10 percent owner, officer: Chief Quantum Tech. Officer 815 BLANCH AVENUE, NORWOOD NJ 07648
Carl Scott Weimer director 4751 SUMMERLIN PLACE, LONGMONT CO 80503
Michael C Turmelle director 27 COUNTRY FARM WAY, STRATHAM NH 03885
William J Mcgann director C/O IMPLANT SCIENCE CORPORATION, 500 RESEARCH DRIVE, WILMINGTON MA 01887
David Charles Morris officer: Chief Revenue Officer 144 DIABLO RANCH COURT, DANVILLE CA 94506
Robert B Fagenson director FAGENSON & CO. INC, 60 BROAD STREET, NEW YORK NY 10004
Bertrand Velge director, 10 percent owner BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND, ROMNEY MARSH, KENT X0 TN299TR
Justin Schreiber director 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Christopher Bruce Roberts director, officer: Chief Financial Officer 1014 PRIRY PLACE, MCLEAN VA 22101
Peter Anthony Schultz 10 percent owner P.O. BOX 9024120, SAN JUAN PR 00902